Miricor Enterprises Holdings Ltd. has announced its annual results for the year ended 31 March 2025, reporting a notable financial turnaround. The company achieved a profit attributable to the owners of approximately HK$10.6 million, contrasting with a loss of approximately HK$12.6 million in the previous year. The basic earnings per share for FY2025 were HK2.65 cents, compared to a basic loss per share of HK3.15 cents in FY2024. The Group's revenue for the year was approximately HK$403.2 million, representing a decrease of HK$91.1 million or 18.4% from the HK$494.3 million reported for the previous year. This decline was primarily due to a reduction in skincare product sales, which fell from HK$119.6 million in FY2024 to HK$52.8 million in FY2025. Despite the challenging consumer market conditions, the medical aesthetics and wellness beauty business remained stable, with the company launching new treatments to meet emerging consumer needs effectively. The skincare retail segment faced a periodic adjustment, prompting the Group to optimize its product mix, enhance customer experiences, and strengthen the integration of online and offline sales channels. The Board has decided not to recommend or declare a dividend for the year ended 31 March 2025.